Profile
Andy Hu worked as a Senior Consultant at Strategic Decisions Group and as a Vice President-Strategy at Predictive Biosciences, Inc. He also worked as a Senior Vice President-Head-Business Development at Dimension Therapeutics, Inc. from 2015 to 2017.
Dr. Hu received his undergraduate degree from Harvard University, his graduate degree from Baylor College of Medicine, and his MBA from Jesse H Jones Graduate School of Business.
Former positions of Andy Hu
Companies | Position | End |
---|---|---|
DIMENSION THERAPEUTICS INC | Corporate Officer/Principal | 2017-09-30 |
Strategic Decisions Group
Strategic Decisions Group Miscellaneous Commercial ServicesCommercial Services Strategic Decisions Group provides consulting solutions. Its solutions include business strategy, portfolio management and allocation, decision and risk analytics, and organization and decision process design. The company was founded by Ronald A. Howard in 1981 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Predictive Biosciences, Inc.
Predictive Biosciences, Inc. Medical/Nursing ServicesHealth Services Predictive Biosciences is a fully-integrated developer of novel molecular diagnostic cancer assays, and a subspecialty, urology-focused provider of anatomic pathology laboratory products and services. The Company pioneered the Clinical Intervention Determining Diagnostic (CIDD) and Multi-Analyte Diagnostic Readout (MADR) approaches to cancer management, leveraging its portfolio of patented biomarkers and clinical algorithms. Based on these approaches, the Company is building a unique portfolio of assays that enable physicians to reliably determine the presence or absence of cancer with very high levels of confidence. Predictive Biosciences' first tests are targeted toward the growing bladder cancer and prostate cancer survivor populations and the large number of individuals undergoing clinical workups for these malignancies. Predictive Biosciences' corporate headquarters and innovation center is located in Lexington, Massachusetts. The Company's commercial division, OncoDiagnostic Laboratory (ODL), is located in Cleveland, Ohio. ODL is a Clinical Laboratory Improvement Act (CLIA)-certified anatomic pathology and molecular diagnostics lab with a national sales force serving urologists, gastroenterologists, dermatologists, gynecologists, and other subspecialty physicians. Founded in 2006, Predictive Biosciences is privately funded by Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates. | Corporate Officer/Principal | - |
Training of Andy Hu
Harvard University | Undergraduate Degree |
Baylor College of Medicine | Graduate Degree |
Jesse H Jones Graduate School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Predictive Biosciences, Inc.
Predictive Biosciences, Inc. Medical/Nursing ServicesHealth Services Predictive Biosciences is a fully-integrated developer of novel molecular diagnostic cancer assays, and a subspecialty, urology-focused provider of anatomic pathology laboratory products and services. The Company pioneered the Clinical Intervention Determining Diagnostic (CIDD) and Multi-Analyte Diagnostic Readout (MADR) approaches to cancer management, leveraging its portfolio of patented biomarkers and clinical algorithms. Based on these approaches, the Company is building a unique portfolio of assays that enable physicians to reliably determine the presence or absence of cancer with very high levels of confidence. Predictive Biosciences' first tests are targeted toward the growing bladder cancer and prostate cancer survivor populations and the large number of individuals undergoing clinical workups for these malignancies. Predictive Biosciences' corporate headquarters and innovation center is located in Lexington, Massachusetts. The Company's commercial division, OncoDiagnostic Laboratory (ODL), is located in Cleveland, Ohio. ODL is a Clinical Laboratory Improvement Act (CLIA)-certified anatomic pathology and molecular diagnostics lab with a national sales force serving urologists, gastroenterologists, dermatologists, gynecologists, and other subspecialty physicians. Founded in 2006, Predictive Biosciences is privately funded by Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates. | Health Services |
Strategic Decisions Group
Strategic Decisions Group Miscellaneous Commercial ServicesCommercial Services Strategic Decisions Group provides consulting solutions. Its solutions include business strategy, portfolio management and allocation, decision and risk analytics, and organization and decision process design. The company was founded by Ronald A. Howard in 1981 and is headquartered in Palo Alto, CA. | Commercial Services |
Dimension Therapeutics, Inc.
Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Andy Hu